共 50 条
- [3] Characterising the chronicity of dupilumab-associated ocular surface disease: an analysis of a retrospective case series BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
- [5] Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (05): : 586 - 589
- [9] Ocular surface disease associated with dupilumab treatment for atopic diseases OCULAR SURFACE, 2021, 19 : 151 - 156